1.
Am J Trop Med Hyg
; 32(5): 1181-3, 1983 Sep.
Article
in English
| MEDLINE
| ID: mdl-6625071
ABSTRACT
Cambendazole was used for the treatment of strongyloidiasis in 40 hospitalized patients, given in a single dose of 5 mg/kg body weight. According to the criteria adopted, parasitological cure was obtained in 100% of cases. Side effects were negligible, and did not require interruption of treatment. We therefore conclude that cambendazole is at present the most effective agent for the therapy of human strongyloidiasis.